Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Super-enhancer lncs to cardiovascular development and disease.
Samir Ounzain1, Thierry Pedrazzini1
1Experimental Cardiology Unit, Department of Medicine, University of Lausanne Medical School, Switzerland.
Super-enhancers (SEs) and their long noncoding RNAs (lncRNAs) are key regulators of heart development and disease. Targeting this genomic landscape offers promising therapeutic strategies for cardiovascular conditions.
Area of Science:
- Cardiovascular Biology
- Genomics
- Molecular Biology
Background:
- Gene expression in cardiac development and disease relies on transcriptional enhancers.
- Super-enhancers (SEs) are critical regulators in cellular gene regulatory networks.
- Long noncoding RNAs (lncRNAs) linked to SEs are vital for enhancer function.
Purpose of the Study:
- To review the emerging roles of SEs and their lncRNAs in cardiovascular development and disease.
- To highlight the therapeutic potential of targeting SEs and lncRNAs in cardiovascular conditions.
Main Methods:
- Literature review of studies on super-enhancers and lncRNAs in cardiovascular contexts.
- Analysis of the regulatory mechanisms involving SEs and lncRNAs in cardiac gene expression.
Main Results:
- SEs and their associated lncRNAs significantly influence cardiovascular development and pathological remodeling.
- These elements are integral to the gene regulatory networks governing heart function.
Conclusions:
- The SE-lncRNA axis represents a crucial frontier in understanding cardiovascular biology.
- Targeting this genomic landscape holds potential for novel ncRNA-based therapeutics for cardiovascular diseases.
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Heart Failure II: Pathophysiology

